Therefore, several selected markers such as CX3CR1, A100A4, KLRG1, S1PR5, and S100A8 were investigated in cancer mouse models and patients with lung cancer to verify the feasibility of utilizing these markers to identify non‐responders and predict immunotherapy efficacy. Here, KLRG1 is linked to cancer.